Co-Diagnostics PE ratio CODX

Share price divided by earnings per share over the last twelve months, since 2020.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 6.1×; Mar 2023
6-year median: 6.0×
6-year range: 3.4× to 90.5×
Peer median: 9.4×

Co-Diagnostics has no meaningful PE ratio today: it lost $24.03 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Mar 2023, at 6.1×.

On the days it had one over the last 6 years, its median was 6.0×, from 3.4× in Sep 2022 to 90.5× in Aug 2020.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	6.1×	5.4×	6.5×
2022	5.4×	3.4×	7.8×
2021	6.3×	4.5×	19.1×
2020	10.4×	10.4×	90.5×

Against its peers

Companies in Healthcare nearest Co-Diagnostics' size, closest first, today.

Company	PE ratio
CODXCo-Diagnostics	n/m
OXBROXBRIDGE RE HOLDINGS	47.5×
EDUCEducational Development	5.4×
GTIMGood Times Restaurants	6.1×
MDRRMedalist Diversified	2.5×
BCGBinah Capital	6.7×
VIPVulcan Infrastructure & Power	17.9×
MXCMexco Energy	13.4×
CKXCKX Lands	7.4×
MSGMMotorsport Games	11.4×
ATCHAtlasClear	15.8×
Peer median	9.4×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Co-Diagnostics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.